Vontobel Holding’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Vontobel Holding's JAZZ Position: Q2 2026 in Review
Vontobel Holding increased its Jazz Pharmaceuticals (JAZZ) stake by 0.39% in Q2 2026, buying an estimated $1.53K and bringing the position to 1,783 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.
Vontobel Holding first reported a position in JAZZ in Q2 2021 and has held it in 21 quarters since. The position peaked at $754K in Q1 2024. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Vontobel Holding held 1,783 shares of Jazz Pharmaceuticals worth $430K as of Q2 2026.
- Vontobel Holding bought 7 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.53K.
- Jazz Pharmaceuticals made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1104 holding.
- Vontobel Holding first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
- Vontobel Holding's Jazz Pharmaceuticals position peaked at $754K in Q1 2024.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.